Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy

Background and aims. Patients with intrahepatic cholestasis of pregnancy (ICP) benefit from ursodeoxycholic acid (UDCA) treatment. Since there is still certain reluctance to use UDCA in pregnant women, mainly due to warnings in the official SPC information in respective drug leaflets, our objective...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Antonin Parízek, Patrik Šimják, Andrej Cerný, Alena Šestinová, Anna Zdenková, Martin Hill, Michaela Dušková, Martin Procházka, Radovan Vlk, Zuzana Kokrdová, Michal Koucký, Libor Vitek
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2016-09-01
coleção:	Annals of Hepatology
Assuntos:	Drug safety Fetal complications Intrahepatic cholestasis of pregnancy Pregnancy Ursodeoxycholic acid
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1665268119306398
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!